Skip to content
mena-header

MIDDLE EAST & NORTH AFRICA

The region supplies products with international brand equity, as well as regionally recognised medicines which are supplied across multiple territories within Middle East and North Africa (“MENA”).

Key Countries

Algeria
Egypt
Morocco
Saudi Arabia
Turkey
United Arab Emirates

middle-east-and-north-africa
  • MENA growth will be mainly driven by Egypt and Turkey over the next three years.
  • The MENA region is expected to grow in USD by value at 4.6% p.a. four-year CAGR between 2019 and 2023. The largest markets are expected to be Turkey, Saudi Arabia, Egypt, Algeria, UAE and Morocco.

Source: IQVIA Market Prognosis

STATISTICS

Number of products launched:

8

(2019: 7)

Average staff turnover:

10%

(2019: 19%)

Number of product recalls:

Nil

(2019: Nil)

Number of work-related fatalities:

Nil

(2019: Nil)

Number of permanent employees

82

June 2020

79

June 2019

Revenue 2020
R’million
2019 (CER)
R’million
Change
%
Regional Brands 841 777 8
Sterile Focus Brands 464 385 21
Anaesthetics Brands 266 255 4
Thrombosis Brands 198 130 52
Total 1 305 1 162 12

Note: Commercial Pharmaceuticals revenue by customer geography.

Scroll To Top